Curis to Present at the Cantor Fitzgerald Global Healthcare Conference
LEXINGTON, Mass., Sept. 26, 2018 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that the Company will present at the Cantor Fitzgerald 2018 Global Healthcare Conference on Tuesday, October 2 at 5:10 PM ET in Track 4 – Grand Ballroom 1, of the InterContinental New York Barclay Hotel in New York.
James Dentzer, the Company's new President & Chief Executive Officer, will provide a brief overview of the Company's pipeline of drug candidates and business strategy.
A live webcast of the presentation will be available by visiting the investor section of Curis' website http://investors.curis.com/events-and-presentations.
A replay of the webcast will be archived on the website for 30 days following the presentation.
SOURCE Curis, Inc.
For further information: Russo Partners, David Schull, Media Relations, firstname.lastname@example.org,(212) 845-4271; Alex Fudukidis, Investor Relations, email@example.com, (646) 942-5632